Company: TCMD
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001558370-25-003924
Chunk: 9

Company: TACTILE SYSTEMS TECHNOLOGY INC
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 9
---
 Meetings |
| Committee Members                                               | Primary Responsibilities                                                              |       in 2024 |
| Valerie L. Asbury (Chair)William W. BurkeB. Vindell Washington​ | ●Identifying qualified individuals to become Board members;                           
 ●Determining the composition of the Board and its committees;                         
 ●Assessing and enhancing the effectiveness of the Board and individual directors; and 
 ●Developing and implementing our Corporate Governance Guidelines.                     |             5 |

The Nominating and Corporate Governance Committee operates pursuant to a written charter approved by the Board, a copy of which is available in the “Investors—Corporate Governance” section of our website at www.tactilemedical.com. A copy of our Corporate Governance Guidelines is also available in the “Investors—Corporate Governance” section of our website at www.tactilemedical.com. The Nominating and Corporate Governance Committee considers candidates for Board membership suggested by its members and the Chief Executive Officer. Additionally, in selecting nominees for directors, the Nominating and Corporate Governance Committee will review candidates recommended by stockholders in the same manner and using the same general criteria as candidates recruited by the Committee and/or recommended by the Board of Directors. Any stockholder who wishes to recommend a candidate for consideration by the Committee as a nominee for director

| ​  | ​                                |
| 18 | Tactile Systems Technology, Inc. |

should follow the procedures described above under “Procedures for Selecting and Nominating Director Candidates.” The Nominating and Corporate Governance Committee will also consider whether to nominate any person proposed by a stockholder in accordance with the provisions of our Bylaws relating to stockholder nominations as described in this Proxy Statement under the heading “Questions and Answers About the Annual Meeting – What is the deadline for submitting a stockholder proposal for the 2026 annual meeting?” Compliance and Reimbursement Committee Our Board of Directors has determined that each member of the Compliance and Reimbursement Committee is “independent” as that term is defined in the applicable Nasdaq Stock Market rules.

| ​                                                                 | ​                                                                                                                                                                                                                          |             ​ |
| ​                                                                 | ​                                                                                                                                                                                                                          | 

# of Meetings |
| Committee Members                                                 | Primary Responsibilities                                                                                                                                                                                                   |       in 2024 |
| B. Vindell Washington (Chair)Raymond O. HuggenbergerLaura G. King | ●Assisting the Board of Directors in overseeing our regulatory compliance activities;                                                                                                                                      
 ●Monitoring and evaluating our compliance with regulatory requirements to which we are subject;